Hammar Tora, Hamqvist Sara, Zetterholm My, Jokela Päivi, Ferati Mexhid
Department of Medicine and Optometry, The eHealth Institute, Linnaeus University, 391 82 Kalmar, Sweden.
Department of Media and Journalism, Linnaeus University, 391 82 Kalmar, Sweden.
Pharmacy (Basel). 2021 Mar 24;9(2):69. doi: 10.3390/pharmacy9020069.
Drug-drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert physicians or pharmacists about DDIs are common, and there is an extensive body of research about CDSS for professionals. Information about DDIs is commonly requested by patients, but little is known about providing similar support to patients. The aim of this scoping review was to explore and describe current knowledge about providing digital DDI services for patients. Using a broad search strategy and an established framework for scoping reviews, 19 papers were included. The results show that although some patients want to check for DDIs themselves, there are differences between patients, in terms of demands and ability. There are numerous DDI services available, but the existence of large variations regarding service quality implies potential safety issues. The review includes suggestions about design features but also indicates a substantial knowledge gap highlighting the need for further research about how to best design and provide digital DDI to patients without risking patient safety or having other unintended consequences.
药物相互作用(DDIs)对患者安全构成重大问题。电子健康解决方案有潜力解决这一问题,并通过为医护人员和患者提供数字服务来总体改善药物管理。用于提醒医生或药剂师注意药物相互作用的临床决策支持系统(CDSS)很常见,并且有大量关于面向专业人员的临床决策支持系统的研究。患者通常会询问有关药物相互作用的信息,但对于为患者提供类似支持的情况却知之甚少。本范围综述的目的是探索和描述有关为患者提供数字药物相互作用服务的现有知识。采用广泛的搜索策略和既定的范围综述框架,纳入了19篇论文。结果表明,尽管一些患者希望自己检查药物相互作用,但患者之间在需求和能力方面存在差异。有许多可用的药物相互作用服务,但服务质量存在很大差异意味着存在潜在的安全问题。该综述包括有关设计特征的建议,但也指出了一个重大的知识空白,突出表明需要进一步研究如何在不危及患者安全或产生其他意外后果的情况下,以最佳方式为患者设计和提供数字药物相互作用服务。